266 related articles for article (PubMed ID: 37870698)
1. Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders.
Oishi N; Ahmed R; Feldman AL
Curr Hematol Malig Rep; 2023 Dec; 18(6):252-263. PubMed ID: 37870698
[TBL] [Abstract][Full Text] [Related]
2. Indolent T-Cell/Natural Killer-Cell Lymphomas/Lymphoproliferative Disorders of the Gastrointestinal Tract-What Have We Learned in the Last Decade?
Wang XG; Yin WH; Wang HY
Lab Invest; 2024 Apr; 104(4):102028. PubMed ID: 38382808
[TBL] [Abstract][Full Text] [Related]
3. New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.
Quintanilla-Martinez L; Swerdlow SH; Tousseyn T; Barrionuevo C; Nakamura S; Jaffe ES
Virchows Arch; 2023 Jan; 482(1):227-244. PubMed ID: 36216980
[TBL] [Abstract][Full Text] [Related]
4. New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA; Brown LE; Prakash S; Bhargava P
Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
[TBL] [Abstract][Full Text] [Related]
5. Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas.
Feldman AL; Laurent C; Narbaitz M; Nakamura S; Chan WC; de Leval L; Gaulard P
Virchows Arch; 2023 Jan; 482(1):265-279. PubMed ID: 36210383
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS; Oon ML; Wang S; Tan SY; Ng SB
Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
[TBL] [Abstract][Full Text] [Related]
7. T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update.
van Vliet C; Spagnolo DV
Pathology; 2020 Jan; 52(1):128-141. PubMed ID: 31727264
[TBL] [Abstract][Full Text] [Related]
8. Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update.
Matnani R; Ganapathi KA; Lewis SK; Green PH; Alobeid B; Bhagat G
Hematol Oncol; 2017 Mar; 35(1):3-16. PubMed ID: 27353398
[TBL] [Abstract][Full Text] [Related]
9. What is new in the classification of peripheral T cell lymphomas?
de Leval L; Bisig B
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):128-135. PubMed ID: 38047948
[TBL] [Abstract][Full Text] [Related]
10. Mature T-cell and NK-cell lymphomas: updates on molecular genetic features.
Lewis NE; Sardana R; Dogan A
Int J Hematol; 2023 Apr; 117(4):475-491. PubMed ID: 36637656
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal T- and NK-cell lymphomas and indolent lymphoproliferative disorders.
Soderquist CR; Bhagat G
Semin Diagn Pathol; 2020 Jan; 37(1):11-23. PubMed ID: 31522873
[TBL] [Abstract][Full Text] [Related]
12. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L
Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602
[TBL] [Abstract][Full Text] [Related]
13. The 2017 WHO update on mature T- and natural killer (NK) cell neoplasms.
Matutes E
Int J Lab Hematol; 2018 May; 40 Suppl 1():97-103. PubMed ID: 29741263
[TBL] [Abstract][Full Text] [Related]
14. Update on the Classification of and Diagnostic Approaches to Mature T-Cell Lymphomas.
Zhang X; Zhou J; Han X; Wang E; Zhang L
Arch Pathol Lab Med; 2022 Aug; 146(8):947-952. PubMed ID: 34524423
[TBL] [Abstract][Full Text] [Related]
15. American Registry of Pathology Expert Opinions: Recommendations for the diagnostic workup of mature T cell neoplasms.
Vega F; Amador C; Chadburn A; Feldman AL; Hsi ED; Wang W; Medeiros LJ
Ann Diagn Pathol; 2020 Dec; 49():151623. PubMed ID: 32947231
[TBL] [Abstract][Full Text] [Related]
16. Possible Concomitant Aggressive NK Cell Leukemia and EBV-positive T-cell lymphoma; Using the online beta version of WHO-HAEM5 and videoconferencing software to make diagnoses accessible in an emerging economy.
Dayton VJ; Hoang Thien D; Xinh PT; Arries C; Sang NN; Linh NNN; Lien NP; Dung PC
Diagn Pathol; 2023 Oct; 18(1):111. PubMed ID: 37803436
[TBL] [Abstract][Full Text] [Related]
17. Biology and genetics of extranodal mature T-cell and NKcell lymphomas and lymphoproliferative disorders.
Lewis NE; Zhou T; Dogan A
Haematologica; 2023 Dec; 108(12):3261-3277. PubMed ID: 38037802
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell neoplasm: biology and pathology.
Ham MF; Ko YH
Int J Hematol; 2010 Dec; 92(5):681-9. PubMed ID: 21132576
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas.
Falini B; Martino G; Lazzi S
Leukemia; 2023 Jan; 37(1):18-34. PubMed ID: 36460764
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous lymphoproliferative disorders: Back to the future.
Willemze R
J Cutan Pathol; 2024 Jun; 51(6):468-476. PubMed ID: 38499969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]